Minimum concentration of Amphotericin B in serum according to the formulation, dose, and daily or prolonged intermittent therapeutic regimen.
Leticia Aparecida SchiaveErika NascimentoGilberto Gambero GasparFernando Crivelenti VilarEdson Zangiacomi MartinezCristiane Masetto de GaitaniRoberto MartinezPublished in: Revista da Sociedade Brasileira de Medicina Tropical (2020)
By evaluating the Cmin of amphotericin B, we demonstrated the therapeutic potential of its intermittent use including in the consolidation phase of neurocryptococcosis treatment, despite the great variability in serum levels among patients.